Stuart S Winkler, Chunqiao Tian, Yovanni Casablanca, Nicholas W Bateman, Suzanne Jokajtys, Calen W Kucera, Christopher M Tarney, John K Chan, Michael T Richardson, Daniel S Kapp, Cheng-I Liao, Chad A Hamilton, Charles A Leath, Megan Reddy, Michele L Cote, Timothy D O'Connor, Nathaniel L Jones, Rodney P Rocconi, Matthew A Powell, John Farley, Craig D Shriver, Thomas P Conrads, Neil T Phippen, G Larry Maxwell, Kathleen M Darcy
OBJECTIVE: This study investigated the risk of an aggressive endometrial cancer (EC) diagnosis by race, ethnicity, and country of origin to further elucidate histologic disparities in non-Hispanic Black (NHB), Hispanic, Asian/Pacific Islander (API), American Indian/Alaskan Native (AIAN) vs. non-Hispanic White (NHW) patients, particularly in Hispanic or API subgroups. METHODS: Patient diagnosed between 2004 and 2020 with low grade (LG)-endometrioid endometrial cancer (ECC) or an aggressive EC including grade 3 EEC, serous carcinoma, clear cell carcinoma, mixed epithelial carcinoma, or carcinosarcoma in the National Cancer Database were studied...
January 25, 2024: Gynecologic Oncology